FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
About Evrysdi Evrysdi is an SMN2-splicing modifier designed to increase functional SMN protein production. With the introduction of a new tablet formulation, Evrysdi now offers an alternative ...
NKGen Biotech Receives U.S. FDA Fast Track Designation for Troculeucel for the Treatment of Moderate Alzheimer’s Disease
The Fast Track designation accelerates troculeucel’s path to U.S. FDA submission for the treatment of patients with moderate Alzheimer’s ...
AVEO Oncology, an LG Chem company, Announces Tivozanib Presentations at ASCO GU 2025
AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions ...
9 reasons you should ditch Chrome for Android and use Firefox instead
G oogle Chrome has been dominant and the default for so long that it’s easy to forget there are other options. But default ...
Azorobotics20h
How the United States AI Regulatory Landscape Differs from the EU and UK
AI companies in the US operate within a complex regulatory landscape shaped by multiple agencies and industry-specific laws.